100958-73-4 Usage
Uses
Used in Chemical and Pharmaceutical Industries:
Benzothiazole, 2,7-diamino(6CI) is used as an intermediate in the production of various chemicals and pharmaceuticals. Its unique chemical structure allows for the synthesis of a wide range of compounds, making it a valuable building block in these industries.
Used in Dye and Pigment Synthesis:
Benzothiazole, 2,7-diamino(6CI) is utilized as a building block in the synthesis of dyes and pigments. Its chemical properties enable the creation of a variety of colorants for different applications.
Used in Rubber Industry:
In the rubber industry, Benzothiazole, 2,7-diamino(6CI) serves as an accelerator for vulcanization. Its presence speeds up the process of cross-linking rubber molecules, improving the efficiency and performance of rubber products.
Used in Agricultural Chemical Production:
Benzothiazole, 2,7-diamino(6CI) is also used in the production of agricultural chemicals. Its unique properties contribute to the development of effective and efficient agrochemicals for various applications in agriculture.
Used in Medical Research and Drug Development:
Due to its unique chemical structure and properties, Benzothiazole, 2,7-diamino(6CI) may have potential uses in medical research and drug development. It can be explored for its potential in creating new pharmaceutical compounds and contributing to advancements in medicine.
Check Digit Verification of cas no
The CAS Registry Mumber 100958-73-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,0,9,5 and 8 respectively; the second part has 2 digits, 7 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 100958-73:
(8*1)+(7*0)+(6*0)+(5*9)+(4*5)+(3*8)+(2*7)+(1*3)=114
114 % 10 = 4
So 100958-73-4 is a valid CAS Registry Number.
100958-73-4Relevant articles and documents
ACTIVATORS OF THE RETINOIC ACID INDUCIBLE GENE "RIG-1" PATHWAY AND METHODS OF USE THEREOF
-
Paragraph 0193, (2020/03/02)
The present invention is directed to compounds of Formula (I), which are activators of the RIG-I pathway.